Table 2. Characteristics of Patients, with Nodules Stratified by VRR < 50.0% and ≥ 50.0%.

	Patients with Nodules VRR < 50% at 12-Month Follow-Up	Patients with Nodules VRR ≥ 50% at 12-Month Follow-Up	P
Number of patients	31	73	-
Sex (male/female)	6/25	12/61	0.779
Age (years) (median; 25.0–75.0%)	54 (41–65)	54 (46–66)	0.887
TSH (mIU/L) (median; 25.0–75.0%)	1.1 (0.8–1.6)	1.3 (0.9–2)	0.780
Non-spongiform/spongiform	20/11	28/45	0.018
Energy delivered (J) (median; 25.0–75.0%)	6006 (3617–9008)	6200 (4057–7920)	0.451
Energy delivered/mL (median; 25.0–75.0%)	521 (415–667)	477 (333–603)	0.642
Nodule volume nodule at baseline (mL) (median; 25.0–75.0%)	12 (7–17)	13 (8–19)	0.821
VRR at 12-month follow-up (%) (median; 25.0–75.0%)	36 (21–45)	66 (59–74)	< 0.001